Literature DB >> 20095993

Esophageal motion during radiotherapy: quantification and margin implications.

R J Cohen1, K Paskalev, S Litwin, R A Price, S J Feigenberg, A A Konski.   

Abstract

The purpose was to evaluate interfraction and intrafraction esophageal motion in the right-left (RL) and anterior-posterior (AP) directions using computed tomography (CT) in esophageal cancer patients. Eight patients underwent CT simulation and CT-on-rails imaging before and after radiotherapy. Interfraction displacement was defined as differences between pretreatment and simulation images. Intrafraction displacement was defined as differences between pretreatment and posttreatment images. Images were fused using bone registries, adjusted to the carina. The mean, average of the absolute, and range of esophageal motion were calculated in the RL and AP directions, above and below the carina. Thirty-one CT image sets were obtained. The incidence of esophageal interfraction motion > or =5 mm was 24% and > or =10 mm was 3%; intrafraction motion > or =5 mm was 13% and > or =10 mm was 4%. The average RL motion was 1.8 +/- 5.1 mm, favoring leftward movement, and the average AP motion was 0.6 +/- 4.8 mm, favoring posterior movement. Average absolute motion was 4.2 mm or less in the RL and AP directions. Motion was greatest in the RL direction above the carina. Coverage of 95% of esophageal mobility requires 12 mm left, 8 mm right, 10 mm posterior, and 9 mm anterior margins. In all directions, the average of the absolute interfraction and intrafraction displacement was 4.2 mm or less. These results support a 12 mm left, 8 mm right, 10 mm posterior, and 9 mm anterior margin for internal target volume (ITV) and can guide margins for future intensity modulated radiation therapy (IMRT) trials to account for organ motion and set up error in three-dimensional planning.

Entities:  

Mesh:

Year:  2010        PMID: 20095993      PMCID: PMC2933373          DOI: 10.1111/j.1442-2050.2009.01037.x

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  17 in total

1.  Movement of the esophagus during left atrial catheter ablation for atrial fibrillation.

Authors:  Eric Good; Hakan Oral; Kristina Lemola; Jihn Han; Kamala Tamirisa; Petar Igic; Darryl Elmouchi; David Tschopp; Scott Reich; Aman Chugh; Frank Bogun; Frank Pelosi; Fred Morady
Journal:  J Am Coll Cardiol       Date:  2005-11-09       Impact factor: 24.094

Review 2.  In-room CT techniques for image-guided radiation therapy.

Authors:  C-M Charlie Ma; Kamen Paskalev
Journal:  Med Dosim       Date:  2006       Impact factor: 1.482

3.  Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus.

Authors:  A Herskovic; K Martz; M al-Sarraf; L Leichman; J Brindle; V Vaitkevicius; J Cooper; R Byhardt; L Davis; B Emami
Journal:  N Engl J Med       Date:  1992-06-11       Impact factor: 91.245

4.  Influence of respiration on recordings of lower esophageal sphincter pressure in humans.

Authors:  R W Welch; J E Gray
Journal:  Gastroenterology       Date:  1982-09       Impact factor: 22.682

5.  Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.

Authors:  J S Macdonald; S R Smalley; J Benedetti; S A Hundahl; N C Estes; G N Stemmermann; D G Haller; J A Ajani; L L Gunderson; J M Jessup; J A Martenson
Journal:  N Engl J Med       Date:  2001-09-06       Impact factor: 91.245

6.  Esophageal cancer: determination of internal target volume for conformal radiotherapy.

Authors:  F Lorchel; J L Dumas; A Noël; D Wolf; J F Bosset; P Aletti
Journal:  Radiother Oncol       Date:  2006-09-07       Impact factor: 6.280

7.  A comparison of multimodal therapy and surgery for esophageal adenocarcinoma.

Authors:  T N Walsh; N Noonan; D Hollywood; A Kelly; N Keeling; T P Hennessy
Journal:  N Engl J Med       Date:  1996-08-15       Impact factor: 91.245

8.  INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy.

Authors:  Bruce D Minsky; Thomas F Pajak; Robert J Ginsberg; Thomas M Pisansky; James Martenson; Ritsuko Komaki; Gordon Okawara; Seth A Rosenthal; David P Kelsen
Journal:  J Clin Oncol       Date:  2002-03-01       Impact factor: 44.544

9.  Fraction size and dose parameters related to the incidence of pericardial effusions.

Authors:  M K Martel; W M Sahijdak; R K Ten Haken; M L Kessler; A T Turrisi
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-01-01       Impact factor: 7.038

10.  Intrathoracic tumour motion estimation from CT imaging using the 3D optical flow method.

Authors:  Thomas Guerrero; Geoffrey Zhang; Tzung-Chi Huang; Kang-Ping Lin
Journal:  Phys Med Biol       Date:  2004-09-07       Impact factor: 3.609

View more
  17 in total

1.  Use of planar kV vs. CBCT in evaluation of setup errors in oesophagus carcinoma radiotherapy.

Authors:  Liliana Martins; Jose Guilherme Couto; Barbara Barbosa
Journal:  Rep Pract Oncol Radiother       Date:  2015-11-14

2.  Feasibility of a novel liquid fiducial marker for use in image guided radiotherapy of oesophageal cancer.

Authors:  Steen Riisgaard de Blanck; Jonas Scherman-Rydhög; Mette Siemsen; Merete Christensen; Lene Baeksgaard; Rasmus Irming Jølck; Lena Specht; Thomas Lars Andresen; Gitte Fredberg Persson
Journal:  Br J Radiol       Date:  2018-07-09       Impact factor: 3.039

3.  Quantifying the interfractional displacement of the gastroesophageal junction during radiation therapy for esophageal cancer.

Authors:  Jingya Wang; Steven H Lin; Lei Dong; Peter Balter; Radhe Mohan; Ritsuko Komaki; James D Cox; George Starkschall
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-03-21       Impact factor: 7.038

4.  Esophageal tolerance to high-dose stereotactic radiosurgery.

Authors:  Bo Mi Lee; Sei Kyung Chang; Seung Young Ko; Seung Hoon Yoo; Hyun Soo Shin
Journal:  Radiat Oncol J       Date:  2013-12-31

5.  Detection of interfraction displacement and volume variance during radiotherapy of primary thoracic esophageal cancer based on repeated four-dimensional CT scans.

Authors:  Jin Zhi Wang; Jian Bin Li; Wei Wang; Huan Peng Qi; Zhi Fang Ma; Ying Jie Zhang; Ting Yong Fan; Qian Shao; Min Xu
Journal:  Radiat Oncol       Date:  2013-09-27       Impact factor: 3.481

6.  Volumetric-modulated arc therapy for the treatment of a large planning target volume in thoracic esophageal cancer.

Authors:  Ahmar S Abbas; Douglas Moseley; Zahra Kassam; Sun Mo Kim; Charles Cho
Journal:  J Appl Clin Med Phys       Date:  2013-05-06       Impact factor: 2.102

7.  Potential for Interfraction Motion to Increase Esophageal Toxicity in Lung SBRT.

Authors:  Anthony Hoai-Nam Pham; Ellen Yorke; Andreas Rimner; Abraham Jing-Ching Wu
Journal:  Technol Cancer Res Treat       Date:  2017-06-02

8.  Esophageal motion characteristics in thoracic esophageal cancer: Impact of clinical stage T4 versus stages T1-T3.

Authors:  Yuta Kobayashi; Miyako Myojin; Shinichi Shimizu; Masao Hosokawa
Journal:  Adv Radiat Oncol       Date:  2016-08-23

Review 9.  Review of Deep Learning Based Automatic Segmentation for Lung Cancer Radiotherapy.

Authors:  Xi Liu; Kai-Wen Li; Ruijie Yang; Li-Sheng Geng
Journal:  Front Oncol       Date:  2021-07-08       Impact factor: 6.244

10.  Motion of the esophagus due to cardiac motion.

Authors:  Jacob Palmer; Jinzhong Yang; Tinsu Pan; Laurence E Court
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.